Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

Reassurances that state clinics will pick up testing are empty – the staff do not exist, and testing has not resumed. State ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...